Connect Sign In
2008426
SLCO1B1 , 1 Variant
SLCO1B1
Ordering Recommendation
Identify individuals at increased risk for statin-related muscle toxicity.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Collect
Lavender (EDTA) or pink (K2EDTA), or yellow (ACD Solution A or B).
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL)
Storage/Transport Temperature
Preferred transport temp: Refrigerated.
Unacceptable Conditions
Plasma or serum. Heparinized specimens. Frozen specimens in glass collection tubes.
Remarks
Counseling and informed consent are recommended for genetic testing. Consent forms are linked above.
New York Clients: informed consent is required with submission.
Stability
Room temperature: 3 days; Refrigerated: 1 week; Frozen: 1 month
Methodology
Polymerase Chain Reaction (PCR) / Fluorescence Monitoring
Performed
Mon, Thu
Reported
5-10 days
Reference Interval
Refer to report
Interpretive Data
Refer to report.
Compliance Category
Laboratory Developed Test (LDT)
Note
Hotline History
N/A
CPT Codes
81328
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2008427 | SLCO1B1, 1 Variant, Specimen | 66746-9 |
| 2008428 | SLCO1B1, 1 Variant,*5 Genotype | 93412-5 |
| 3016893 | EER SLCO1B1 | 11526-1 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- Simvastatin myotoxicity assay
- Statin-induced myopathy assay
SLCO1B1, 1 Variant
